Silikon 1000 aftercare instructions

Key takeaways

Silikon 1000 is a permanent, non-reversible liquid silicone (polydimethylsiloxane) FDA-approved for ophthalmic use but used off-label for facial volume via microdroplet injections.

Sessions are spaced 4-6 weeks apart to allow tissue encapsulation, and permanence requires explicit informed consent covering irreversibility and long-term risks like granuloma formation.

Aftercare covers swelling management, activity restrictions, and multi-session scheduling, and practices must document each phase with structured consent and treatment records.

Practice management software like Pabau simplifies multi-session protocols, consent capture, and post-treatment documentation for practices offering Silikon 1000.

Silikon 1000 is a permanent, non-reversible liquid silicone filler used off-label by trained physicians for facial volume restoration via the microdroplet technique. Unlike dissolvable fillers such as hyaluronic acid and calcium hydroxylapatite, Silikon 1000 cannot be reversed. That distinction must be embedded in informed consent and documented throughout the patient journey.

Practices offering Silikon 1000 face unique documentation challenges:

• Staged sessions require multi-appointment coordination.
• Permanence disclosure demands explicit written acknowledgment.
• Long-term risk management, covering granuloma formation and product migration, depends on detailed aftercare compliance.

This guide covers the clinical essentials, patient selection criteria, and the downloadable aftercare template your team needs to manage Silikon 1000 treatments safely and compliantly.

What is Silikon 1000?

Structured consultation forms should always define what Silikon 1000 is for patients unfamiliar with the product. Silikon 1000 is a purified liquid silicone (polydimethylsiloxane) with a viscosity of exactly 1000 centistokes. The “1000” in the name refers to this specific measurement. The FDA has approved Silikon 1000 exclusively for ophthalmic injection (retinal detachment surgery). All cosmetic and soft-tissue use is strictly off-label.

The defining characteristic of Silikon 1000 is permanence. Unlike temporary fillers that the body gradually metabolizes, Silikon 1000 does not dissolve. Once injected, it remains in the tissue indefinitely. This distinguishes it both clinically and legally, and it must feature prominently in patient consent.

Off-label use of Silikon 1000 for cosmetic purposes carries regulatory complexity. State medical boards permit appropriately licensed physicians to administer off-label medications and devices. Practitioners must still obtain explicit informed consent that acknowledges the off-label status, permanence, and documented risks. A medical spa compliance checklist can help standardize how a practice keeps records of risk disclosure and patient acknowledgment.

• Viscosity: 1000 centistokes (defines the product name and flow characteristics)
• FDA status: Ophthalmic use only (retinal detachment); cosmetic use is off-label
• Permanence: Cannot be reversed or dissolved, unlike hyaluronic acid or other temporary fillers
• Biocompatibility: Minimal inflammatory response in most patients, but delayed granuloma formation is a documented long-term risk
• Regulatory requirement: Informed consent mandatory; off-label status must be disclosed in writing

How to use the aftercare template

The downloadable Silikon 1000 Aftercare Instructions form is structured around five operational steps that mirror the microdroplet injection protocol. Your clinical and administrative teams should follow this sequence for each patient.

1. Pre-treatment consent capture: Present the form at the consultation appointment. The form covers patient identification and medical history screening. It also captures explicit consent covering permanence, off-label status, and documented risks such as granuloma, migration, inflammatory reactions, and inability to reverse treatment. Obtain witnessed signatures from the patient and the treating physician on the consent section.
2. Session scheduling and microdroplet documentation: Silikon 1000 is administered in serial sessions spaced 4-6 weeks apart. Each session involves multiple tiny microdroplets injected into deep dermis, allowing surrounding tissue to encapsulate the silicone before the next layer is added. Document the injection date, treatment area, droplet count, and volume injected in the patient record. Comprehensive patient care workflows help track staged treatment progress across multiple visits.
3. Immediate post-injection care (0-48 hours): The form restricts the first 48 hours: no massage of the treated area and no heavy lifting. It also prohibits strenuous exercise and facial treatments during this window. Swelling and mild bruising are normal. Patients should use ice packs (wrapped in cloth, not direct) and sleep with the head elevated. Document adherence in the follow-up note.
4. Extended aftercare (Week 1-6): During the interval between sessions, patients avoid vigorous facial massage and high-impact exercise. They also avoid extreme heat, such as saunas or intense sunbathing, for at least 4 weeks. Fine-line activity like light walking or desk work is permitted. Prescribe gentle skincare and broad-spectrum SPF 30+ sunscreen, and schedule the follow-up session at week 4-6 per the form’s scheduling section.
5. Long-term management and patient education: Reinforce permanence at each follow-up. The form includes a section on realistic outcomes, covering gradual improvement over sessions and long-term aesthetic goals. It also covers long-term risk disclosure: granuloma formation can occur months or years after injection, and migration is rare but documented. Provide contact information for any delayed complications and maintain detailed records for medico-legal protection.

Use digital consent forms to capture signatures electronically, timestamp the consent, and automatically file a copy in the patient’s medical record. This reduces paper handling and creates an auditable compliance trail.

Who is this aftercare template for?

This template is designed for any med spa, dermatology practice, or cosmetic surgery center offering off-label Silikon 1000 injections. The specific audiences include:

• Med spas and aesthetic practices: Practices offering facial volume restoration, lip augmentation, and cheek contouring with Silikon 1000 need a standardized aftercare protocol. This template ensures all patients receive consistent guidance and acknowledges permanence in writing.
• Dermatology practices: Dermatologists trained in the microdroplet technique use Silikon 1000 for scar correction and facial rejuvenation. The form documents the staged approach and risk disclosure required for off-label use.
• Cosmetic surgery centers: Surgeons running plastic surgery software still need explicit consent workflows for permanent augmentation. This matters most when educating patients about the irreversibility of the procedure.
• Multi-location aesthetic groups: Franchised or group practices benefit from standardized medical spa software that applies the same template across all locations, ensuring regulatory consistency.
• Practitioners transitioning to Silikon 1000: Practitioners experienced with temporary fillers like hyaluronic acid or calcium hydroxylapatite may be new to Silikon 1000. They need a clear aftercare protocol for this different product, and it helps manage patient expectations around permanence and staged sessions.

Benefits of using this aftercare template

Legal and compliance protection: Off-label use requires documented informed consent. The template explicitly discloses permanence, off-label status, and known risks (granuloma formation, migration, inflammatory response). Written acknowledgment protects the practice in the event of adverse outcomes or patient dissatisfaction.

Patient safety through structured aftercare: Silikon 1000 requires staged injections spaced 4-6 weeks apart. Unclear aftercare instructions increase risk of infection, excessive swelling, or poor outcomes. A structured template ensures every patient understands activity restrictions, swelling timelines, and when to contact the practice for complications.

Workflow efficiency and appointment consistency: Multi-session treatments benefit from automated scheduling and documentation. The template’s section on follow-up intervals (4-6 weeks between sessions) integrates with practice scheduling systems, reducing no-shows and ensuring patients return for staged augmentation.

Medico-legal documentation: Detailed records of risk disclosure, patient acknowledgment, and post-treatment instructions create a strong medico-legal foundation. Patient portals let practices send aftercare reminders electronically and track compliance with documented proof of delivery.

Standardization across teams: A consistent template ensures all staff members, including physicians, nurses, and aestheticians, communicate identical aftercare guidance. This reduces confusion and improves patient trust in the practice’s expertise.

Managing long-term risk and permanence

Silikon 1000’s permanence is both its strength and its greatest liability. Unlike temporary fillers that fade within months, Silikon 1000 results are meant to last a lifetime, and so are any complications. Practice teams must educate patients about delayed risks and maintain vigilant follow-up.

Granuloma formation: A documented long-term risk, granuloma (inflammatory nodules around silicone particles) can develop months or even years after injection. Symptoms include palpable lumps, persistent redness, or pain. Patients should be educated on this risk upfront and instructed to report any unusual sensations during follow-ups.

Migration: Migration is rare with the microdroplet technique, thanks to precise placement in the deep dermis. It can still happen if silicone is injected too superficially or if the patient engages in aggressive facial massage. The aftercare template explicitly prohibits massage to minimize this risk.

Informed consent revisited: Some practitioners schedule annual follow-up appointments specifically to reinforce permanence and discuss any long-term changes. Automated clinical documentation can streamline these review notes, automatically flagging patients for long-term follow-up and maintaining a running record of risk discussions.

Silikon 1000 success depends on realistic patient expectations. A detailed aftercare template, combined with detailed post-treatment guidance and clear communication, sets the stage for satisfied patients and protected practices.

How Pabau supports Silikon 1000 consent and scheduling

Most practices managing Silikon 1000 still rely on paper consent forms and manual appointment tracking across a treatment series that spans several months. Staff copy risk disclosures by hand, chase missing signatures before each session, and cross-reference paper charts to confirm which stage a patient has reached.

Pabau replaces that process with digital consent forms that timestamp every signature and file the completed form straight into the patient record. Appointment scheduling sends automatic reminders ahead of each 4-6 week session. Pabau Scribe structures the treatment note from the consultation, so risk discussions get documented without extra typing.

The result is a dated record of every disclosure and session that a practice can produce quickly if a patient raises a concern years later. Read the case study on Intrigue Cosmetic Clinic to see how another aesthetic practice put digital consent and scheduling to work.

Grow Without Compromising Patient Care

See how private GPs reduce admin, improve clinical safety, and increase revenue with Pabau.

Book a demo

Conclusion

Silikon 1000’s permanence demands meticulous informed consent, staged session planning, and detailed aftercare documentation. This free downloadable template provides the clinical and legal foundation your team needs to safely offer this treatment. Pabau’s digital forms and multi-session appointment scheduling automate the administrative complexity around it. Book a demo to see how your practice can streamline Silikon 1000 workflows and reduce compliance risk.

Continue your research

Need another aftercare form to adapt? Dermal filler aftercare form uses a similar consent-and-signature structure that transfers well to other injectable treatments.

Managing consent for another permanent treatment? SAFELipo aftercare template covers the same staged consent and recovery documentation for a different permanent procedure.

Documenting clinical decisions with speed? Pabau Scribe, our AI scribe, automatically structures aftercare notes and risk discussions, saving time and ensuring consistency across treatments.

Refining your multi-session booking workflow? Scheduling patients effectively walks through practical tactics for keeping a staged treatment series on track.

Frequently asked questions